Modus Therapeutics Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 23, 2022 at 04:27 am EDT
Modus Therapeutics Holding AB (publ) reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was SEK 2.99 million compared to SEK 2.53 million a year ago. Basic loss per share from continuing operations was SEK 0.19 compared to SEK 0.26 a year ago.
For the six months, net loss was SEK 6.06 million compared to SEK 3.96 million a year ago. Basic loss per share from continuing operations was SEK 0.38 compared to SEK 0.43 a year ago.